Morgan Stanley’s SEQUENOM INC NEW SQNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-122,293
| Closed | -$111K | – | 6666 |
|
|
2016
Q2 | $111K | Buy |
122,293
+38,420
| +46% | +$45.8K | ﹤0.01% | 5199 |
|
|
2016
Q1 | $118K | Buy |
83,873
+5,975
| +8% | +$8.91K | ﹤0.01% | 5238 |
|
|
2015
Q4 | $127K | Sell |
77,898
-4,381
| -5% | -$7.5K | ﹤0.01% | 5291 |
|
|
2015
Q3 | $143K | Sell |
82,279
-260,180
| -76% | -$637K | ﹤0.01% | 5252 |
|
|
2015
Q2 | $1.04M | Buy |
342,459
+235,963
| +222% | +$888K | ﹤0.01% | 4169 |
|
|
2015
Q1 | $421K | Sell |
106,496
-12,006
| -10% | -$44.1K | ﹤0.01% | 4777 |
|
|
2014
Q4 | $438K | Sell |
118,502
-14,590
| -11% | -$47.3K | ﹤0.01% | 4760 |
|
|
2014
Q3 | $396K | Sell |
133,092
-54,220
| -29% | -$198K | ﹤0.01% | 4727 |
|
|
2014
Q2 | $725K | Sell |
187,312
-36,531
| -16% | -$107K | ﹤0.01% | 4304 |
|
|
2014
Q1 | $549K | Sell |
223,843
-13,640
| -6% | -$32.5K | ﹤0.01% | 4483 |
|
|
2013
Q4 | $555K | Sell |
237,483
-1,323,697
| -85% | -$3.14M | ﹤0.01% | 4378 |
|
|
2013
Q3 | $4.17M | Buy |
1,561,180
+655,374
| +72% | +$2.2M | ﹤0.01% | 2607 |
|
|
2013
Q2 | $3.81M | Buy |
+905,806
| New | +$3.62M | ﹤0.01% | 2580 |
|
Morgan Stanley's SQNM Position: Q3 2016 in Review
Morgan Stanley sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 122,293 shares — an estimated $111K sold.
Morgan Stanley first reported a position in SQNM in Q2 2013 and held it in 13 quarters. The position peaked at $4.17M in Q3 2013. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.
- Morgan Stanley reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
- Morgan Stanley sold 122,293 SEQUENOM INC NEW shares in Q3 2016, an estimated $111K.
- Morgan Stanley first reported a position in SEQUENOM INC NEW in Q2 2013 and held it in 13 quarters.
- Morgan Stanley's SEQUENOM INC NEW position peaked at $4.17M in Q3 2013.
- 0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.